FdaApplication
ANDA 205921
Identifiers
- fda_app_no: ANDA205921
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABS LTD |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE;ORAL |
1 product